Cancer

Good and bad extracellular vesicles in health and disease

By Bench Side Story — 1 year ago

Associate Professor Joy Wolfram has joint appointments in the School of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland, and through her work at the AIBN, she aims to develop a new paradigm of therapeutics (using nanotechnology and cell products) to treat life-threatening diseases that are major causes of death globally, including cardiovascular disease, kidney disease, and breast cancer.

Post Views: 2,608

Role of metabolic dysfunction in advanced prostate cancer

By Bench Side Story — 1 year ago

Dr Gunter was drawn to the area of prostate cancer research and the intersection between chronic metabolic disorders and their emerging relationship to cancer. Her strengths include expertise in the metabolic syndrome, insulin signalling and metabolism, and she has a demonstrated record of successful and productive research projects in metabolic research where she now applies her efforts to understanding the role of metabolic dysfunction in advanced prostate cancer.

Post Views: 928

Next generation nanomedicine and radiopharmaceuticals to treat cancer

By Bench Side Story — 2 years ago

Finding better ways of treating cancer, aside from finding a cure, aim to provide a better quality of life for those who suffer from it.

Professor Thurecht’s work focuses on nanomedicine and spans across the Australian Institute for Bioengineering and Nanotechnology and the Centre for Advanced Imaging, at the University of Queensland in Australia.

Post Views: 1,761

Engineering bacteria to detect colorectal cancer cells

By Bench Side Story — 2 years ago

An international team of researchers from Adelaide and the United States has engineered bacteria capable of detecting mutated DNA released from colorectal cancer cells, opening the door to faster disease detection.